Crystalvue Medical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Wei Wang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.8% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
The Returns On Capital At Crystalvue Medical (GTSM:6527) Don't Inspire Confidence
Apr 05
Has Crystalvue Medical Corporation (GTSM:6527) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 10Consider This Before Buying Crystalvue Medical Corporation (GTSM:6527) For The 5.2% Dividend
Feb 10Are Crystalvue Medical's (GTSM:6527) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 20
The Returns At Crystalvue Medical (GTSM:6527) Provide Us With Signs Of What's To Come
Dec 30Could The Market Be Wrong About Crystalvue Medical Corporation (GTSM:6527) Given Its Attractive Financial Prospects?
Dec 09CEO
Wei Wang
no data
Tenure
Wei Wang serves as the Chairman of the Board and Chief Executive at Crystalvue Medical Corporation.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the board & CEO | no data | no data | 0.79% NT$ 17.2m | |
| GM & Director | no data | no data | 2.11% NT$ 45.8m | |
| Director | no data | no data | no data | |
| Supervisor | no data | no data | no data | |
| Supervisor | no data | no data | no data | |
| Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Director | 1.5yrs | no data | 0.025% NT$ 540.5k | |
| Independent Director | less than a year | no data | no data |
0.6yrs
Average Tenure
Experienced Board: 6527's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 01:11 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Crystalvue Medical Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yu-Ying Yang | KGI Securities Co. Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |